These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32522372)

  • 1. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
    Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
    Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema multiforme in the context of SARS-Coronavirus-2 infection.
    Sánchez-Velázquez A; Falkenhain D; Rivera Díaz R
    Med Clin (Barc); 2020 Aug; 155(3):141. PubMed ID: 32475615
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 7. Covid-19 treatment update: follow the scientific evidence.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
    [No Abstract]   [Full Text] [Related]  

  • 8. Auditory Cinchonism in COVID Era.
    Saniasiaya J; Kulasegarah J
    Ear Nose Throat J; 2020 Nov; 99(9):597-598. PubMed ID: 32744901
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
    Rani S; Grover S; Mehra A; Sahoo S
    Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
    [No Abstract]   [Full Text] [Related]  

  • 10. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
    Shih RD; Johnson HM; Maki DG; Hennekens CH
    Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
    [No Abstract]   [Full Text] [Related]  

  • 12. Facts, not Fear: Safety of Hydroxychloroquine.
    Kuraitis D; Murina A
    Am J Med Sci; 2020 Aug; 360(2):199-200. PubMed ID: 32560964
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
    Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
    Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
    Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
    Vitte J; Michel M; Mezouar S; Diallo AB; Boumaza A; Mege JL; Desnues B
    Front Immunol; 2020; 11():2159. PubMed ID: 32983179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
    Funnell SGP; Dowling WE; Muñoz-Fontela C; Gsell PS; Ingber DE; Hamilton GA; Delang L; Rocha-Pereira J; Kaptein S; Dallmeier KH; Neyts J; Rosenke K; de Wit E; Feldmann H; Maisonnasse P; Le Grand R; Frieman MB; Coleman CM
    Nat Commun; 2020 Aug; 11(1):4253. PubMed ID: 32848158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.